Informed consent
Item
provision of informed consent
boolean
C0021430 (UMLS CUI [1])
Gender and age
Item
male and female patients aged 18 years and over
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
ms patients that are already currently treated or eligible for treatment with anticholinergic drugs
Item
ms patients that are already currently treated or eligible for treatment with anticholinergic drugs
boolean
C0026769 (UMLS CUI [1,1])
C2827774 (UMLS CUI [1,2])
C0242896 (UMLS CUI [1,3])
C0026769 (UMLS CUI [2,1])
C1548635 (UMLS CUI [2,2])
C0242896 (UMLS CUI [2,3])
Previous confirmation of ms according to mcdonald criteria and level of disability less than 6.5 on the kutzke scale, current stable status for 6 months
Item
patient with previously confirmed multiple sclerosis according to mcdonald criteria and level of disability less than 6.5 on the kutzke scale and have been stable for 6 months
boolean
C0026769 (UMLS CUI [1,1])
C0679228 (UMLS CUI [1,2])
C0012605 (UMLS CUI [2,1])
C0451246 (UMLS CUI [2,2])
C0521116 (UMLS CUI [3,1])
C0205360 (UMLS CUI [3,2])
Presence of bladder symptoms such as urgency, frequency, incontinence, nocturia, pvr
Item
the patient has all or any bladder symptoms; urgency, frequency, incontinence, nocturia, pvr
boolean
C1457887 (UMLS CUI [1,1])
C0232841 (UMLS CUI [1,2])
C0085606 (UMLS CUI [2])
C2584336 (UMLS CUI [3])
C0042024 (UMLS CUI [4])
C0028734 (UMLS CUI [5])
C0429774 (UMLS CUI [6,1])
C1439885 (UMLS CUI [6,2])
Frequency symptoms > 8 voiding per 24h
Item
the patient has frequency symptoms > 8 voiding per 24 h
boolean
C2584336 (UMLS CUI [1])
pvr > 50 ml, measured during screening phase and the randomization visit
Item
the patient has pvr > 50 ml, measured at two repetitive bladder scan measurements during the screening phase as well as the randomization visit
boolean
C3839465 (UMLS CUI [1,1])
C4060656 (UMLS CUI [1,2])
Adequate mobility to lower limbs, sufficient hand function and ability to practice cic
Item
adequate mobility to lower limbs, sufficient hand function and ability to practice cic at least three times daily
boolean
C0231434 (UMLS CUI [1,1])
C0018563 (UMLS CUI [1,2])
C0231434 (UMLS CUI [2,1])
C1140621 (UMLS CUI [2,2])
C0085732 (UMLS CUI [3,1])
C2936294 (UMLS CUI [3,2])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Urinary tract infection
Item
ongoing symptomatic urinary tract infection (uti) as judged by investigator
boolean
C0042029 (UMLS CUI [1])
Involvement in planning and conduct of the study
Item
involvement in the planning and conduct of the study (applies to both astra tech staff or staff at the study site)
boolean
C2603343 (UMLS CUI [1,1])
C0851286 (UMLS CUI [1,2])
Practice of cic prior to the study
Item
the patient practices cic prior the study
boolean
C1514463 (UMLS CUI [1,1])
C2936294 (UMLS CUI [1,2])
Status post sphincterectomy
Item
the patient has undergone a sphincterectomy
boolean
C1262069 (UMLS CUI [1])
Progressive relapsing- remitting ms
Item
progressive "relapsing- remitting ms" as judged by the investigator
boolean
C1335499 (UMLS CUI [1,1])
C0751967 (UMLS CUI [1,2])
Severe non-compliance to protocol
Item
severe non-compliance to protocol as judged by the investigator and/or astra tech
boolean
C0457432 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Concurrent participation in other study that might have an impact on the outcome of this, as judged by investigator
Item
the patient is participating in other study that might have an impact on the outcome of this, as judged by investigator
boolean
C2348568 (UMLS CUI [1,1])
C4054723 (UMLS CUI [1,2])
Pvr > 250 ml, measured during screening phase and the randomization visit
Item
pvr > 250 ml, measured at two repetitive bladder scan measurements during the screening phase as well as the randomization visit and or if bladder voiding efficiency (bve) at visit 2 (randomization) is 50percent or less than visit 1 (screening)
boolean
C3839465 (UMLS CUI [1,1])
C4060656 (UMLS CUI [1,2])